Targeting Inflammation by Anthocyanins as the Novel Therapeutic Potential for Chronic Diseases: An Update

Aleksandra Kozłowska1, Tomasz Dzierżanowski1

  • 1Department of Social Medicine and Public Health, Medical University of Warsaw, 02-776 Warsaw, Poland.

Insights

Anthocyanins show promise in reducing inflammation and oxidative stress, potentially aiding chronic disease management. Further long-term clinical trials are needed to confirm these anti-inflammatory effects in diverse populations.

Area of Science:

  • Nutritional Science
  • Biochemistry
  • Pathophysiology

Background:

  • Low-grade chronic inflammation (LGCI) and oxidative stress are key contributors to numerous diseases.
  • Polyphenols, such as anthocyanins, modulate inflammatory responses and endogenous antioxidant systems.

Purpose of the Study:

  • To review clinical studies from the past five years on the anti-inflammatory and antioxidant roles of anthocyanins.
  • To assess the potential of anthocyanins in managing chronic diseases and promoting health.

Main Methods:

  • Narrative review of clinical studies published within the last five years.
  • Analysis of research on anthocyanins' effects on inflammatory markers and oxidative stress.

Main Results:

  • Anthocyanin supplementation shows potential in regulating pro-inflammatory markers in healthy individuals and those with chronic diseases.
  • Inconsistencies were noted between randomized controlled trials and meta-analyses regarding anthocyanins' efficacy.
  • Evidence suggests anthocyanins can exert anti-inflammatory and antioxidant effects both in vitro and in vivo.

Conclusions:

  • Anthocyanins hold promise for the prevention and treatment of chronic diseases by mitigating inflammation and oxidative stress.
  • Further long-term, well-designed clinical trials are essential to quantify the progression of inflammation and confirm the benefits of anthocyanins.
  • Clinicians can utilize this review to understand the significance of anthocyanins in patient care for chronic conditions.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
13.3K
Inflammation01:38

Inflammation

Overview
56.6K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
246
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
80
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
264
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
465